Mindy and Jon Gray gift $55M to Penn’s Basser Center for BRCA for Cancer Interception Institute
Penn alumni Mindy and Jon Gray have gifted $55 million to the University of Pennsylvania’s Basser Center at the Abramson Cancer Center to establish the Basser Cancer Interception Institute, which aims to target the early stages of hereditary cancers.
University Of Pennsylvania Receives $55 Million Gift To Study, Treat Hereditary Cancers
The University of Pennsylvania has received a $55 million gift for the study and treatment of hereditary cancers. The gift, from Penn alumni Mindy and Jon Gray, will be used to establish the Basser Cancer Interception Institute, at the Basser Center.
Integrating Genetic Testing in Electronic Health Records Saves Time, Penn Study Finds
Ordering and managing genomic testing in electronic health records significantly cut the time Penn Medicine clinicians spent doing it.
Penn receives $55M gift from Blackstone president toward breast cancer research
The University of Pennsylvania’s Basser Center for BRCA has received a $55 million gift toward cancer treatment and disease interception from two school alums.
$55 Million Gift to Penn is Aimed at Stopping Breast Cancer Before It Starts
Mindy Gray and her husband, Blackstone president Jon Gray, gave the money in honor of Mindy's sister Faith Basser.
Blackstone’s Gray Gives UPenn $55 Million for Cancer Prevention
Jon and Mindy Gray’s gift will fund an institute focused on early detection of breast, ovarian, pancreatic and prostate cancers.
$55 Million Gift Creates New “Cancer Interception” Institute at Penn’s Basser Center for BRCA to Stop Hereditary Cancers at the Earliest Stages
Funding for the Institute from Mindy and Jon Gray will propel early detection and prevention of breast, ovarian, pancreatic, and prostate cancers.
Study Shows High Rate of Actionable Mutations in Lung Cancer
Kara Maxwell, MD, PhD was invited as a discussant on research relating to germline genetic testing and whether it should be done for all lung cancer patients is probably a bit premature.
Breast Cancer Drug Trial Results in "Unheard-Of" Survival
Susan Domchek, MD, presented at ASCO on clinical trials of the experimental drug, Enhertu, that showed slowed tumor growth in breast cancer patients & extended life with advanced cancers.
Genetic testing: A life-saver for Black women and breast cancer
Dana Clark, MS, Basser Center genetic counselor, spoke about the value of genetic testing in cancer prevention, while dispelling myths associated with access and cost. Her patient, Kimyatta, shares her story and strong hereditary link to the disease.